Health-care shares were generally higher in pre-market trade Tuesday.
In health-care stocks news, Omeros ( OMER ) shares are down pre-market after the company said it was suspending a trial of its drug candidate to treat schizophrenia and Huntington's disease while it evaluates an observation from a non-clinical study in rats.
Shares in the company were down 9.55% to $12.50 during Tuesday's pre-market trading session. Over the past 52 weeks, the company has traded between $6.92 and $18.80.
Meanwhile, Veeva Systems' ( VEEV ) technology was tapped by inVentiv Health Clinical, a supplier of drug development services, to replace its electronic trial master file (eTMF) content management system with Veeva Vault eTMF.
Shares in the company were down 0.11% to $28.28 during Tuesday's pre-market trading session. Over the past 52 weeks, the company has traded between $17.11 and $49.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.